- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotics in the pipeline: a literature review (2017–2020)
Authors
Keywords
-
Journal
INFECTION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-05
DOI
10.1007/s15010-021-01709-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- To Push or To Pull? In a Post-COVID World, Supporting and Incentivizing Antimicrobial Drug Development Must Become a Governmental Priority
- (2021) J. Cama et al. ACS Infectious Diseases
- Cost Analysis of New Antibiotics to Treat Multidrug-Resistant Bacterial Infections: Mind the Gap
- (2021) Dafna Yahav et al. Infectious Diseases and Therapy
- A Comparison of Treatment Outcomes Between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients With Imipenem-Nonsusceptible Bacterial Infections
- (2020) Keith S. Kaye et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
- (2020) Michelle L Brown et al. Open Forum Infectious Diseases
- Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers
- (2020) Junzhen Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections
- (2020) Stephanie Noviello et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
- (2020) Ivan Titov et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
- (2019) James A. McKinnell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Community-Acquired Bacterial Pneumonia
- (2019) Roman Stets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
- (2019) William O’Riordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline — The Newest Tetracycline
- (2019) Henry F. Chambers NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of IV-to-Oral Lefamulin, a Pleuromutilin Antibiotic, for Treatment of Community-Acquired Bacterial Pneumonia: The Phase 3 LEAP 1 Trial
- (2019) Thomas M File et al. CLINICAL INFECTIOUS DISEASES
- Clinical research designs to study treatment effects for multidrug-resistant bacteria
- (2019) Mical Paul et al. CLINICAL MICROBIOLOGY AND INFECTION
- Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial
- (2019) Marcus Y Chen et al. LANCET INFECTIOUS DISEASES
- A Phase-3 Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults with Community-acquired Bacterial Pneumonia (DEFINE-CABP)
- (2019) Juan P Horcajada et al. Open Forum Infectious Diseases
- Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
- (2018) Yutaka Saisho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
- (2018) Stephanie N Taylor et al. CLINICAL INFECTIOUS DISEASES
- A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study
- (2018) William O’Riordan et al. CLINICAL INFECTIOUS DISEASES
- Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
- (2018) David B. Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection
- (2018) Keith S. Kaye et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Lefamulin: Review of a promising novel pleuromutilin antibiotic
- (2018) Michael P. Veve et al. PHARMACOTHERAPY
- Ridinilazole—a novel antibiotic for treatment of Clostridium difficile infection
- (2018) Niels Steinebrunner et al. Journal of Thoracic Disease
- An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria
- (2018) David B Huang et al. Open Forum Infectious Diseases
- Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
- (2018) Sohita Dhillon DRUGS
- In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli
- (2018) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Plazomicin: A Next-Generation Aminoglycoside
- (2018) Kristy M. Shaeer et al. PHARMACOTHERAPY
- Antibiotic resistance: a rundown of a global crisis
- (2018) Bilal Aslam et al. Infection and Drug Resistance
- 1363. Sulopenem Activity Against Enterobacteriaceae Isolates From Patients With Urinary Tract Infection or Intra-Abdominal Infection
- (2018) Sailaja Puttagunta et al. Open Forum Infectious Diseases
- 1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
- (2018) Keith Kaye et al. Open Forum Infectious Diseases
- LB6. Oral Lefamulin Is Safe and Effective in the Treatment of Adults With Community-Acquired Bacterial Pneumonia (CABP): Results of Lefamulin Evaluation Against Pneumonia (LEAP 2) Study
- (2018) Elizabeth Alexander et al. Open Forum Infectious Diseases
- Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
- (2017) Adrian Towse et al. HEALTH POLICY
- Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study
- (2017) J Pullman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy
- (2017) Bryan J Donald et al. Drug Design Development and Therapy
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Improved Outcomes with Plazomicin (PLZ) Compared with Colistin (CST) in Patients with Bloodstream Infections (BSI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE): Results from the CARE Study
- (2017) James A McKinnell et al. Open Forum Infectious Diseases
- Plazomicin Vs. Meropenem for Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): Diagnosis-specific Results From the Phase 3 EPIC Study
- (2017) Daniel J Cloutier et al. Open Forum Infectious Diseases
- Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
- (2016) S. Ken Tanaka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia
- (2016) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
- (2016) Carlos M Barrera et al. LANCET INFECTIOUS DISEASES
- In VivoActivities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
- (2015) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition ofNeisseria gonorrhoeaeType II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914
- (2015) Gunther Kern et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
- (2010) M. Paul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inappropriate antimicrobial use and potential solutions: a Middle Eastern perspective
- (2010) Jaffar A Al-Tawfiq et al. Expert Review of Anti-Infective Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now